![discount label](https://static.cymitquimica.com/public/img/discount.png)
Product Information
BRD5529 is an e3 ubiquitin ligase inhibitor. It has been shown to inhibit the inflammatory response by reducing the production of cytokines and reactive oxygen species. BRD5529 has been shown to be effective in treating bowel diseases and insulin resistance, which may be due to its ability to reduce the production of pro-inflammatory cytokines. This drug also appears to have a regulatory effect on the immune system, suppressing inflammatory responses.
Chemical properties
Technical inquiry about: 3D-IEC48878 BRD5529
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.